InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Lentini Renee, Autre. Director active across 1 companies, notably ImmunoGen, Inc.. In total, 4 disclosures have been published. The latest transaction was disclosed on 31 December 2021 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€9,6771,957 shares@ €4.944855.3% of flow
Common Stock
SEC:0001179110-22-000101·
€9,6771,957 shares@ €4.944827.6% of flow
Common Stock
SEC:0001179110-22-000101:0·
€7,8351,683 shares@ €4.655644.7% of flow
Common Stock
SEC:0001179110-21-007313·
€7,8351,683 shares@ €4.655622.4% of flow
Common Stock
SEC:0001179110-21-007313:0·
4 of 4 declarations
About Lentini Renee
Renee Lentini serves as Vice President of Finance and Principal Accounting Officer at ImmunoGen, Inc. In this role, she is responsible for overseeing the financial management and accounting operations of the company. Lentini plays a key role in developing financial strategies and ensuring compliance with accounting standards. Her expertise in finance is essential to support ImmunoGen's growth.
